|
?:abstract
|
-
COVID-19, the infection caused by the recently identified coronavirus, is currently a disease with no pharmaceutical weapons against it Researchers across the world are racing to find the investigation of existing drugs for new therapeutic purposes (Drug repositioning, also called drug repurposing) to develop safe and effective COVID-19 treatments Other research directions include the development of a COVID-19 vaccine Developing new vaccines takes time, and they must be rigorously tested and confirmed safe via clinical trials before they can be routinely used in humans WHO launched the multinational trial to jumpstart the search for coronavirus drugs The drugs to be tested are the antiviral drug remdesivir;a combination of two HIV drugs, lopinavir and ritonavir, lopinavir, and ritonavir plus interferon beta and the antimalarial drug chloroquine and Hydroxy Chloroquine All show some evidence of effectiveness against the SARS-CoV 2 virus, which causes COVID-19, either in vitro and animal studies The four drugs or combinations will be compared to what is called a standard of care the regular support hospitals treating these patients use at present, such as supplementary oxygen when desired Clinical trials in China and several other countries have been conducting on drugs such as Remdesivir, Lopinavir + Ritonavir, Tenofovir, Oseltamivir, Baloxivir marboxil, Umifenovir, Novaferon, IFNs, Chloroquine, Traditional Chinese Medicines: Lianhua Qingwen
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}